Regeneron Pharmaceuticals Inc. (REGN)
Total Asset Turnover
since 2005
Beginner level
Calculation
Regeneron Pharmaceuticals Inc., total asset turnover, long-term trends, calculation
Total asset turnover | = | Revenues1 | ÷ | Total assets1 | |
---|---|---|---|---|---|
Dec 31, 2018 | 0.57 | = | 6,710,800 | ÷ | 11,734,500 |
Dec 31, 2017 | 0.67 | = | 5,872,227 | ÷ | 8,764,286 |
Dec 31, 2016 | 0.70 | = | 4,860,427 | ÷ | 6,973,466 |
Dec 31, 2015 | 0.73 | = | 4,103,728 | ÷ | 5,609,132 |
Dec 31, 2014 | 0.73 | = | 2,819,557 | ÷ | 3,871,827 |
Dec 31, 2013 | 0.71 | = | 2,104,745 | ÷ | 2,951,013 |
Dec 31, 2012 | 0.66 | = | 1,378,477 | ÷ | 2,080,490 |
Dec 31, 2011 | 0.34 | = | 445,824 | ÷ | 1,323,583 |
Dec 31, 2010 | 0.42 | = | 459,074 | ÷ | 1,089,432 |
Dec 31, 2009 | 0.51 | = | 379,268 | ÷ | 741,202 |
Dec 31, 2008 | 0.36 | = | 238,457 | ÷ | 670,038 |
Dec 31, 2007 | 0.13 | = | 125,024 | ÷ | 936,258 |
Dec 31, 2006 | 0.11 | = | 63,447 | ÷ | 585,090 |
Dec 31, 2005 | 0.16 | = | 66,193 | ÷ | 423,501 |
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
1 US$ in thousands
Comparison to Competitors
Regeneron Pharmaceuticals Inc., total asset turnover, long-term trends, comparison to competitors
Regeneron Pharmaceuticals Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Pfizer Inc. | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2018 | 0.57 | 0.46 | 0.55 | 0.16 | 0.34 | 0.53 | 0.64 | 0.56 | 0.34 | 0.53 | 0.51 | 0.34 |
Dec 31, 2017 | 0.67 | 0.36 | 0.40 | 0.13 | 0.27 | 0.52 | 0.62 | 0.51 | 0.37 | 0.49 | 0.46 | 0.31 |
Dec 31, 2016 | 0.70 | 0.40 | 0.39 | 0.11 | 0.28 | 0.50 | 0.58 | 0.55 | 0.53 | 0.51 | 0.42 | 0.31 |
Dec 31, 2015 | 0.73 | 0.49 | 0.43 | 0.11 | 0.29 | 0.55 | 0.52 | 0.56 | 0.62 | 0.53 | 0.39 | 0.29 |
Dec 31, 2014 | 0.73 | 0.49 | 0.72 | 0.25 | 0.28 | 0.68 | 0.47 | 0.53 | 0.71 | 0.57 | 0.43 | 0.29 |
Dec 31, 2013 | 0.71 | 0.51 | 0.64 | 0.38 | 0.28 | 0.58 | 0.42 | 0.66 | 0.48 | 0.54 | 0.42 | 0.30 |
Dec 31, 2012 | 0.66 | 0.59 | 0.68 | 0.42 | 0.31 | 0.54 | 0.49 | 0.66 | 0.44 | 0.55 | 0.45 | 0.32 |
Dec 31, 2011 | 0.34 | 0.64 | — | 0.68 | 0.31 | 0.56 | 0.64 | 0.72 | 0.47 | 0.57 | 0.46 | 0.36 |
Dec 31, 2010 | 0.42 | 0.59 | — | 0.61 | 0.34 | 0.58 | 0.63 | 0.74 | 0.64 | 0.60 | 0.43 | 0.35 |
Dec 31, 2009 | 0.51 | 0.59 | — | 0.47 | 0.36 | 0.51 | 0.61 | 0.80 | 0.67 | 0.65 | 0.24 | 0.23 |
Dec 31, 2008 | 0.36 | 0.70 | — | 0.69 | 0.40 | 0.48 | 0.70 | 0.70 | 0.72 | 0.75 | 0.51 | 0.43 |
Dec 31, 2007 | 0.13 | 0.65 | — | 0.72 | 0.41 | 0.37 | 0.74 | 0.70 | 0.64 | 0.75 | 0.50 | 0.42 |
Dec 31, 2006 | 0.11 | 0.62 | — | 0.53 | 0.41 | 0.31 | 0.70 | 0.71 | 0.63 | 0.76 | 0.51 | 0.42 |
Dec 31, 2005 | 0.16 | 0.77 | — | 0.53 | 0.41 | 0.29 | 0.68 | 0.60 | 0.48 | 0.87 | 0.49 | 0.44 |
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Regeneron Pharmaceuticals Inc., total asset turnover, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
Regeneron Pharmaceuticals Inc. | Pharmaceuticals & Biotechnology | |
---|---|---|
Dec 31, 2018 | 0.57 | 0.42 |
Dec 31, 2017 | 0.67 | 0.37 |
Dec 31, 2016 | 0.70 | 0.37 |
Dec 31, 2015 | 0.73 | 0.38 |
Dec 31, 2014 | 0.73 | 0.44 |
Dec 31, 2013 | 0.71 | 0.43 |
Dec 31, 2012 | 0.66 | 0.46 |
Dec 31, 2011 | 0.34 | 0.48 |
Dec 31, 2010 | 0.42 | 0.48 |
Dec 31, 2009 | 0.51 | 0.40 |
Dec 31, 2008 | 0.36 | 0.58 |
Dec 31, 2007 | 0.13 | 0.57 |
Dec 31, 2006 | 0.11 | 0.55 |
Dec 31, 2005 | 0.16 | 0.57 |
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).
Comparison to Industry (Health Care)
Regeneron Pharmaceuticals Inc., total asset turnover, long-term trends, comparison to industry (health care)
Regeneron Pharmaceuticals Inc. | Health Care | |
---|---|---|
Dec 31, 2018 | 0.57 | 0.54 |
Dec 31, 2017 | 0.67 | 0.48 |
Dec 31, 2016 | 0.70 | 0.49 |
Dec 31, 2015 | 0.73 | 0.47 |
Dec 31, 2014 | 0.73 | 0.54 |
Dec 31, 2013 | 0.71 | 0.54 |
Dec 31, 2012 | 0.66 | 0.55 |
Dec 31, 2011 | 0.34 | 0.58 |
Dec 31, 2010 | 0.42 | 0.57 |
Dec 31, 2009 | 0.51 | 0.51 |
Dec 31, 2008 | 0.36 | 0.68 |
Dec 31, 2007 | 0.13 | 0.66 |
Dec 31, 2006 | 0.11 | 0.64 |
Dec 31, 2005 | 0.16 | 0.63 |
Based on: 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11), 10-K (filing date: 2015-02-12), 10-K (filing date: 2014-02-13), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-17), 10-K (filing date: 2010-02-18), 10-K (filing date: 2009-02-26), 10-K (filing date: 2008-02-27), 10-K (filing date: 2007-03-12), 10-K (filing date: 2006-02-28).